Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
Lu, C-Y, Tsai, H-L, Uen, Y-H, Hu, H-M, Chen, C-W, Cheng, T-L, Lin, S-R, Wang, J-YVolume:
108
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2012.595
Date:
March, 2013
File:
PDF, 240 KB
english, 2013